IR vs ORGO · P/E 49, rev $3.90B vs rev $81.0M
Ingersoll Rand Inc (IR) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported IR revenue for 2026-06-30 was $3.90B. Net income was $448.9M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
IR currently screens at market cap $28.27B and trailing P/E 48.8. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the IR and ORGO stock pages for the full models.
Not investment advice.